OncoZenge AB (DE:8LY)
:8LY
Advertisement

OncoZenge AB (8LY) Revenue

Compare
0 Followers

OncoZenge AB Revenue

OncoZenge AB had a revenue of 117.00K in the quarter ending Jun 30, 2025, with -95.69%. This bring the company's revenue in the last twelve months to 2.83M, Decreased 4.27%. In the fiscal year ending Dec 31, 2024, OncoZenge AB had annual revenue of 1.00K with -66.67% growth.
Revenue (ttm)
2.83M
Revenue Growth
P/S Ratio
7332.56
Revenue/Employee
€1,000
Employees
1
Market Cap
€7.33M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.00K-2.00K+33.34%
Dec 31, 2023
3.00K-300,000.00%
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis